Community/Retail

Pharmacists’ accessibility and interactions with the public may help increase HPV vaccine coverage.

A team of researchers from the City University of New York found fewer than 1 in 10 suitable PrEP candidates are currently taking PrEP, in a new article published in Journal of Acquired Immune Deficiency Syndrome.

Workaholics and procrastinators can't win when it comes to play. If you play, you feel guilty; and if you don't play, you become so tired that you can’t do your best work.

Have you ever considered pursuing a post-graduate year 2 pharmacy residency in infectious disease?

Smokers who receive telephone-based smoking cessation counseling shortly after undergoing lung cancer screening may be more likely to quit smoking, a new Georgetown Lombardi-led study finds.

Learn about the new products and expanded indications approved by the FDA in January 2017.

China has issued scheduling controls against synthetic opioid fentanyl-class substances, DEA officials announced.

Harm reduction may be more effective than use reduction in minimizing fentanyl’s deadly contribution to increasing overdoses, a new report argues.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The art of communication, especially when delivering a presentation, is a critical skill for pharmacists to cultivate.

One of the main reasons I chose to attend Howard University College of Pharmacy was its International Experiential Rotation program.

Here are 7 tips for gaining and leveraging earned media placements so you can tell your story.

The following apps can help you manage your spending, track your finances, monitor your savings and transfer funds.

Need an escape from the pharmacy or have a break from pharmacy school and want to get some fresh air? Here are 8 must see national parks you should explore.

The researchers discovered that IgA-coated E coli were abundant in the fecal samples of patients with both Crohn’s disease and spondyloarthritis.

The FDA has expanded the indication of Boehringer Ingelheim Pharmaceuticals’ Spiriva Respimat (tiotropium bromide).

A new study published today in The New England Journal of Medicine casts new light on the severity of the opioid abuse crisis in the United States. Nearly one out of 48 people who are newly prescribed an opioid will become long-term users, the study’s lead author said.

Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota, according to data presented at the annual Conference on Retroviruses and Opportunistic Infections in Seattle.

The Little Clinic has introduced "We'll Hold Your Spot," an online tool that allows consumers to reserve a place in line before they get to a clinic.

Newly published research from the CVS Health Research Institute emphasizes the role a private retailer can play in restricting access to tobacco and improving public health.

The FDA has approved Valeant Pharmaceuticals’ Siliq (brodalumab) injection for subcutaneous use in adults with psoriasis.

The Kroger Co. has been named one of the top US corporations for inclusion by Omnikal.

To help prevent and treat neutropenia, we routinely use Granulocyte Colony Stimulating Factors (G-CSF) for patients undergoing myelosuppressive chemotherapy.

The program comprises 2 studies with over 1000 patients who previously achieved viral suppression on a 3- or 4-drug antiretroviral regimen.

Unsafe fungal and bacterial contaminants have been detected in some sources of medical marijuana, according to a report from UC Davis.

An experimental drug is improving survival rates in a common and aggressive canine cancer, and may also have implications for cancer treatments in human patients.

Better hospital supply chain management leads to better quality of care and supports patient safety, according to a new Cardinal Health survey of hospital staff and decision makers.

Rite Aid has announced that naloxone is now available at more than 630 pharmacies in Georgia, Louisiana, Tennessee, Utah, Virginia and West Virginia without a prescription.